clinical trial · NCT01396408
A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours
Canadian Cancer Trials Group·phase2·active not recruiting·n = 137
Advanced Rare TumoursSunitinibTemsirolimus
brief summary
This research is being done because there is no treatment that will cure this type of cancer. Although some types of chemotherapy can cause this cancer to shrink for a time, better options are needed.
started
Feb 9, 2012
primary completion
Jul 6, 2015
completion
Jun 30, 2026
last updated
Mar 27, 2026
detailed description
The purpose of this study is to find out what effects the study drugs - sunitinib or temsirolimus - will have on this type of cancer. The study will begin by finding out if sunitinib can shrink the cancer. If sunitinib does not work, temsirolimus will be tested next.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol